15 May 2012
Novavax is enrolling patients in a second Phase 1 clinical trial of a vaccine that could prevent a potential bird flu pandemic.
03 May 2012
Mucosis has announced the publication of preclinical data showing that FluGEM provides superior cross-protection against influenza virus.
21 Mar 2012
Bend Research has announced an initiative to expand its scientific and engineering expertise into biotherapeutics.
02 Mar 2012
FluMist Quadrivalent contains four strains (two type A strains and two type B lineages) to help provide broad protection against circulating influenza A and B.
13 Jan 2012
The firm was fined $93,000 by an Argentine court for failing to obtain parental consent to conduct the trials.
04 Jan 2012
The new use for Prevnar 13 was approved under the agency's accelerated approval pathway, which allows for earlier approval of treatments for serious and life-threatening illnesses.
06 Dec 2011
Takeda will establish a Vaccine Business Division to strengthen the Company’s foundations for expansion of its vaccine business on a global scale.
28 Nov 2011
The UK will select Merck's Gardasil vaccine instead of GSK's rival product Cervarix to prevent girls from contracting the HPV virus.
28 Nov 2011
A clinical phase I/II trial will be initiated within the next few months on 12 patients with metastatic renal cancer.
25 Nov 2011
Data demonstrated a median overall survival of 24.6 months from diagnosis, which is consistent with the finding of two earlier studies.
Items per Page 10 | Total 5 Pages | Go to Page [2] [3] [4] [5] Next»»
